Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT

Fig. 7

Decision curve analyses of the nomogram, RS-Com and clinical model. X-axis and y-axis showed the threshold probability and net benefit, respectively. The red, blue, and green lines represent decisions made by the nomogram, clinical model and RS-Com, respectively. The black line represents the assumption that all patients were NAT-low and not treated, whereas the gray line represents the hypothesis that all patients are NAT-high and received treatment

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us